NO965591D0 - Kombinasjonsbehandling av HIV-infeksjon - Google Patents
Kombinasjonsbehandling av HIV-infeksjonInfo
- Publication number
- NO965591D0 NO965591D0 NO965591A NO965591A NO965591D0 NO 965591 D0 NO965591 D0 NO 965591D0 NO 965591 A NO965591 A NO 965591A NO 965591 A NO965591 A NO 965591A NO 965591 D0 NO965591 D0 NO 965591D0
- Authority
- NO
- Norway
- Prior art keywords
- hiv infection
- combination treatment
- treatment
- combination
- hiv
- Prior art date
Links
- 208000031886 HIV Infections Diseases 0.000 title 1
- 208000037357 HIV infectious disease Diseases 0.000 title 1
- 238000011284 combination treatment Methods 0.000 title 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26708594A | 1994-06-27 | 1994-06-27 | |
| PCT/US1995/007690 WO1996000068A2 (en) | 1994-06-27 | 1995-06-23 | Combination therapy for hiv infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO965591D0 true NO965591D0 (no) | 1996-12-27 |
| NO965591L NO965591L (no) | 1996-12-27 |
Family
ID=23017251
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO965591A NO965591L (no) | 1994-06-27 | 1996-12-27 | Kombinasjonsbehandling av HIV-infeksjon |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0767664A2 (no) |
| JP (1) | JPH10503178A (no) |
| AU (1) | AU2863895A (no) |
| CA (1) | CA2193221A1 (no) |
| CZ (1) | CZ375196A3 (no) |
| FI (1) | FI965196A0 (no) |
| HU (1) | HUT76546A (no) |
| IL (1) | IL114208A0 (no) |
| MX (1) | MX9700036A (no) |
| NO (1) | NO965591L (no) |
| PL (1) | PL317876A1 (no) |
| SK (1) | SK163996A3 (no) |
| WO (1) | WO1996000068A2 (no) |
| ZA (1) | ZA955269B (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6689761B1 (en) * | 1995-02-01 | 2004-02-10 | Merck & Co., Inc. | Combination therapy for HIV infection |
| US6045829A (en) * | 1997-02-13 | 2000-04-04 | Elan Pharma International Limited | Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers |
| EP0872233A1 (en) * | 1997-04-14 | 1998-10-21 | Janssen Pharmaceutica N.V. | Antiretroviral compositions with improved bioavailability |
| GB2324242A (en) * | 1997-04-18 | 1998-10-21 | Atindra Nath Chakrabarty | Medicaments for treating viral infections |
| IL148801A0 (en) | 1999-09-24 | 2002-09-12 | Janssen Pharmaceutica Nv | Antiviral compositions |
| EP4215900A1 (en) | 2015-09-23 | 2023-07-26 | Malvern Panalytical Limited | Particle characterisation |
-
1995
- 1995-06-19 IL IL11420895A patent/IL114208A0/xx unknown
- 1995-06-23 HU HU9603567A patent/HUT76546A/hu unknown
- 1995-06-23 PL PL95317876A patent/PL317876A1/xx unknown
- 1995-06-23 JP JP8503245A patent/JPH10503178A/ja active Pending
- 1995-06-23 WO PCT/US1995/007690 patent/WO1996000068A2/en not_active Application Discontinuation
- 1995-06-23 AU AU28638/95A patent/AU2863895A/en not_active Withdrawn
- 1995-06-23 CA CA002193221A patent/CA2193221A1/en not_active Abandoned
- 1995-06-23 EP EP95923935A patent/EP0767664A2/en not_active Withdrawn
- 1995-06-23 MX MX9700036A patent/MX9700036A/es unknown
- 1995-06-23 SK SK1639-96A patent/SK163996A3/sk unknown
- 1995-06-23 CZ CZ963751A patent/CZ375196A3/cs unknown
- 1995-06-26 ZA ZA955269A patent/ZA955269B/xx unknown
-
1996
- 1996-12-23 FI FI965196A patent/FI965196A0/fi not_active Application Discontinuation
- 1996-12-27 NO NO965591A patent/NO965591L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0767664A2 (en) | 1997-04-16 |
| CZ375196A3 (en) | 1997-07-16 |
| MX9700036A (es) | 1997-04-30 |
| JPH10503178A (ja) | 1998-03-24 |
| FI965196A (fi) | 1996-12-23 |
| IL114208A0 (en) | 1995-10-31 |
| HUT76546A (en) | 1997-09-29 |
| WO1996000068A2 (en) | 1996-01-04 |
| HU9603567D0 (en) | 1997-02-28 |
| ZA955269B (en) | 1996-02-02 |
| SK163996A3 (en) | 1997-08-06 |
| PL317876A1 (en) | 1997-04-28 |
| WO1996000068A3 (en) | 1996-02-22 |
| AU2863895A (en) | 1996-01-19 |
| NO965591L (no) | 1996-12-27 |
| CA2193221A1 (en) | 1996-01-04 |
| FI965196A0 (fi) | 1996-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO934547D0 (no) | Oral behandling av Helicobacter-in-feksjon | |
| NO924461D0 (no) | Dipyridamol for behandling av proliferaktive sykdommer | |
| FI972681A (fi) | Kynsien sientenvastainen käsittely | |
| FI956339A (fi) | Hypotalaamisen kuukautisten puuttumisen hoitaminen | |
| FI965204A (fi) | Bromelaiinin lääkekäyttö | |
| KR950700707A (ko) | 치과용 치료시스템 | |
| NO940810D0 (no) | Behandling av virusinfeksjoner | |
| FI932847A0 (fi) | HIV-proteasinhibitorer som aer anvaendbara foer behandling av aids | |
| ID21874A (id) | Penggunaan 1-hidroksi-2-piridon untuk pengobatan infeksi urap kulit | |
| NO955258D0 (no) | Medisinsk anvendelse av enzymer | |
| NO965591D0 (no) | Kombinasjonsbehandling av HIV-infeksjon | |
| FI963638A (fi) | Menetelmiä HIV-1-injektion diagnosoimiseksi ja hoitamiseksi | |
| EE03514B1 (et) | Ühendite kombinatsioon HIV infektsiooni või AIDS-i raviks, selle kasutamine ja farmatseutiline kompositsioon | |
| FI971897A0 (fi) | Ihmisen retrovirusinfektion detektointi | |
| NO942756D0 (no) | Behandling av glaucoma | |
| DE59301768D1 (de) | Zahnbehandlungseinheit | |
| AU3530395A (en) | Treatment of viral infections | |
| NO963482D0 (no) | Medisinsk anvendelse av bromelain | |
| GB9419571D0 (en) | Treatment of oral infections | |
| NO20002481D0 (no) | Kombinasjonsterapi for behandling av AIDS | |
| DE69522685D1 (de) | Behandlung von blut-plasma | |
| DE69737088D1 (de) | Therapeutisches agens zur behandlung von fiv infektionen | |
| NO960551D0 (no) | Antistoff basert behandling av HIV infeksjon | |
| EP0655919A4 (en) | TREATMENT OF VIRAL INFECTIONS IN MAN. | |
| AU1389897A (en) | Use of chemokines for the treatment and prevention of hiv infection |